A RISK-AND-EVIDENCE EXPLAINER
Pre-Myopia in Children: Risk, Monitoring and Care Decisions
Understand a pre-myopia finding, the examination questions and prevention evidence. Compare a proposed plan and agree on useful follow-up.Compare the proposed plan’s questions ↓
Pre-myopia describes an increased risk of developing myopia based on the eye examination, age and other factors. It is not a diagnosis from a home checklist. Ask how risk was assessed, when measurements should be repeated and whether any proposed intervention is suitable for this child.
On this page
Understand what the risk label is telling you
A clinician may say a child is at risk of myopia before the child needs distance correction. That can feel confusing: if the child sees well today, what is being monitored? Pre-myopia is a way to describe a higher likelihood of developing myopia based on examination findings, age and other information. It is not a diagnosis from a screen-time questionnaire. [1]
Ask which finding led to the discussion. Was the measured focusing error closer to myopia than expected for the child's age? Has it changed? Does family history add context? A useful explanation connects the label to the examination rather than presenting it as a fixed prediction.
The aim is to agree what happens next. That may include outdoor opportunities, repeat measurements and a discussion of whether an intervention is appropriate. It does not mean every child with a myopic parent should receive the same treatment.
VISUAL GUIDE 1 / 3
A risk discussion starts with an examination
Refraction and the wider assessment
Age, family history and relevant health information
Previous measurements and their comparability
Discuss outdoor opportunities, repeat assessment and the suitability and uncertainty of any intervention.
The risk map shows information a clinician may consider. It does not produce a score, diagnose pre-myopia or assign a percentage chance to a particular child.
Ask how the eyes were measured
Refraction measures how the eye focuses light. In children, clinicians may use drops to relax focusing during the assessment. This is called cycloplegic refraction. Ask what method was used and how it affects interpretation of the result.
A single number needs context. Age matters, and so do previous measurements and the rest of the examination. The International Myopia Institute emphasizes the combination of refraction, age and other measurable risk factors when discussing pre-myopia. A parent should not have to interpret a printout alone. [1]
Axial length is the front-to-back length of the eye, measured from the corneal surface to the retina. It can add information when used appropriately, but a number from one visit is not a universal normal-or-abnormal test for every child. Ask what will be compared over time and whether the measurements are suitable for that comparison.
Bring previous records if available. If measurements came from different practices or devices, ask the clinician how comparable they are. Apparent change and reliable change are not always the same question.
Separate preventing onset from slowing progression
A child who has not developed myopia and a child whose myopia is progressing are different study populations. An intervention may have evidence for one question without answering the other. This is a useful distinction when a clinic, product page or social-media post mentions a treatment percentage.
Ask what the proposed goal is. Is it to delay the start of myopia, slow a measured change after onset or provide clear vision? Also ask what outcome will be used to judge the plan. A treatment discussion is more understandable when the goal is named before the product.
The IMI's 2025 Digest reviews emerging prevention evidence and the need to weigh uncertain outcomes, potential risks, cost and family circumstances. It does not make the same choice appropriate for every child described as pre-myopic. [2]
A plan can still be active without an immediate product decision. Monitoring has a purpose when the next measurement, review point and reasons for earlier contact are clear. “We will watch it” should come with an explanation your family can follow.
Read the prevention evidence in its own setting
The LAMP2 randomized trial enrolled 474 children aged four to nine without myopia in Hong Kong. It compared two atropine concentrations with placebo. At two years, the reported myopia incidence was lower with 0.05% atropine than placebo. The visual shows the actual reported groups and denominators. [3]
VISUAL GUIDE 2 / 3
LAMP2: what the two-year prevention result measured
This is selected research, not a prescription. The trial's setting, entry criteria, follow-up and incomplete retention affect how its findings can be applied. The results do not establish that a drop will permanently prevent myopia in any particular child.
Later research also needs context. ATOM3 investigated 0.01% atropine in young pre-myopic and low-myopic children. Its prevention findings did not establish that this concentration prevented onset in the pre-myopic group. Results from different concentrations, populations or outcomes cannot be treated as interchangeable. [4]
Ask the clinician to explain the evidence for the exact option being proposed, including what is still uncertain. A reassuring brand name or a familiar concentration is not enough to answer that question.
Give outdoor opportunities a practical place
Outdoor time is part of prevention guidance, but families need a routine they can actually use. Ask what opportunities are available across home, school and childcare. A shaded playground, accessible path or ordinary outdoor activity may be easier to maintain than a program that depends on a long journey.
The IMI Digest identifies outdoor time as an important protective factor in prevention discussions. It also recognizes that individual care decisions involve more than a single exposure. Keep the distinction between a supportive routine and a guaranteed outcome clear. [2]
Do not turn the plan into blame. Family history, the child's examination and other influences do not disappear when a family goes outdoors. If myopia develops despite thoughtful routines, the next step is an appropriate care discussion rather than deciding that the child failed.
For more detail on daily planning, use the outdoor-time guide. Bring questions about safe access, disability-related needs and local conditions to the care team. A prevention conversation should make participation easier, not require unsafe or inaccessible activities.
Compare the proposed plan with a few clear questions
If an intervention is offered, ask why it suits this child now. Request the expected benefit in terms you can understand, the likely burden and what would lead to a change. Ask about current local authorization and whether the intended use falls outside the product's approved labeling.
A treatment plan should also name the practical work. Who gives drops or helps with lenses? What follow-up is needed? What happens if the child cannot tolerate the routine? The answers are part of suitability, not details to discover after paying.
VISUAL GUIDE 3 / 3
Compare a proposal with the question it must answer
| Ask about | An answer worth understanding |
|---|---|
| Purpose | Is the goal delaying onset, correcting vision or slowing established progression? |
| Evidence | Does the study match the child, product, concentration and outcome? |
| Practical burden | Who provides care, what monitoring is needed and what costs apply? |
| Review point | What would lead to continuing, changing or stopping the plan? |
The question board does not rank treatments. It helps you compare an actual proposal against a monitoring plan and your child's needs. A clinician should explain adverse effects and any symptoms that require contact for the option under discussion.
Avoid starting a medication, borrowing a sibling's product or changing a concentration based on this article. Prevention research is a reason for an informed professional discussion. It is not a reason to turn an online chart into an individual prescription.
Leave with a monitoring plan you can explain
Ask when the next assessment should occur and what will be measured. The interval should follow the child's risk and findings. A website cannot choose one schedule for every child. Write down the agreed date and who to contact if symptoms arise before it.
Also ask what would count as a meaningful change. The answer may involve refraction, eye-growth measurements and the rest of the examination. It should not depend only on whether the child complains of blur. Some children adapt to gradual changes without describing them.
If the family changes practices, take the prior records and treatment details. This can help the next clinician understand the reasoning behind the plan. Tell them about any difficulty following the routine so that the plan can be reconsidered realistically.
The axial-length article explains measurement language in more detail. The purpose of the next visit is to answer a defined question, rather than collect a new number without knowing how it changes care.
Keep the child involved without making them responsible for risk
Use language that fits the child's age. “We are checking how your eyes grow and helping you see comfortably” is easier to understand than a prediction about future disease. Invite questions about the appointment and ordinary routines.
Adults should carry responsibility for appointments, consent, cost and treatment decisions. A child can help explain what is comfortable or difficult. They should not feel that every reading session or indoor day is a choice that caused a medical problem.
The American Academy of Orthokeratology and Myopia Control (AAOMC) offers resources for families learning about myopia and care options. Use them to prepare questions, alongside the explanation from the professional who examined the child. Their inclusion does not imply a particular intervention is endorsed for this situation. [5]
The most useful outcome is a plan the family understands: why risk was discussed, what the options can and cannot promise, and when the eyes will be reassessed. That creates a practical next step while preserving room to respond to what future measurements actually show.
Your pre-myopia questions
Discussion prompts only. Checks stay on this open page; nothing is submitted or saved. This sheet does not diagnose, choose treatment or determine urgency. Do not delay urgent care to complete it.
CHECK THE EVIDENCE
Sources & references
Research, professional guidance and patient resources. Checked October 22, 2026.
- 1IMI Defining and Classifying MyopiaInternational Myopia Institute · 2019
- 2IMI 2025 DigestInternational Myopia Institute · 2025
- 3Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence: LAMP2Yam et al. · JAMA · 2023
- 4Effect of Low-Dose Atropine on Young Premyopic and Low-Myopic Children: ATOM3ATOM3 investigators · British Journal of Ophthalmology
- 5Patient Resources: Myopia and OrthokeratologyAmerican Academy of Orthokeratology and Myopia Control (AAOMC)
General education. This article does not replace an eye examination, individual advice, or the prescribed care plan.
